Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 24.58 USD 2.12% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Nurix Therapeutics Inc?
Write Note

Nurix Therapeutics Inc
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nurix Therapeutics Inc
Accumulated Depreciation Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Nurix Therapeutics Inc
NASDAQ:NRIX
Accumulated Depreciation
-$26.2m
CAGR 3-Years
-26%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accumulated Depreciation
-$6.9B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nurix Therapeutics Inc's Accumulated Depreciation?
Accumulated Depreciation
-26.2m USD

Based on the financial report for Nov 30, 2023, Nurix Therapeutics Inc's Accumulated Depreciation amounts to -26.2m USD.

What is Nurix Therapeutics Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-25%

Over the last year, the Accumulated Depreciation growth was -33%. The average annual Accumulated Depreciation growth rates for Nurix Therapeutics Inc have been -26% over the past three years , -25% over the past five years .

Back to Top